Quest Pharmatech Inc.
Edmonton, CA· latest recorded location
Quest Pharmatech Inc. is named on 8 US grants and 8 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 8
- Published applications
- 8
- Inventors
- 13
- Granted in 2026 so far
- 0
- Most recent grant
- 3 Oct 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 1 | 2 |
| 2011 | 1 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 3 | 2 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
By publication year.
Technology areas
Share of 16 documents
- A61KMedicines and medical preparations16
- A61PTherapeutic uses of medicines15
- C07CAcyclic or carbocyclic compounds8
- C07DHeterocyclic compounds8
- A61QSpecific use of cosmetics or similar toiletry preparations7
- C07KPeptides6
- Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests3
- A61LMethods or apparatus for sterilising materials or objects in general2
- G01NInvestigating or analysing materials by determining their chemical or physical properties2
- A61NElectrotherapy1
Recent patents
- MUC16 monoclonal antibody and uses thereof3 Oct 2023US 11,773,183 B2
- Methods for improving the bioactivity of therapeutic IgE antibodies for the treatment of disease3 Feb 2015US 8,945,566 B2
- Polymeric nanoparticles for photosensitizers23 Dec 2014US 8,916,205 B2
- Perylenequinone derivatives and uses thereof24 Jun 2014US 8,758,725 B2
- Perylenequinone derivatives and uses thereof10 Jun 2014US 8,747,811 B2
- Muc16 monoclonal antibody and uses thereof8 Apr 2021US 2021/0101994 A1
- Polymeric nanoparticles for photosensitizers19 Jun 2014US 2014/0170229 A1
- Perylenequinone derivatives and uses thereof13 Mar 2014US 2014/0072512 A1
- Perylenequinone derivatives and uses thereof14 Nov 2013US 2013/0304089 A1
- Nanoparticles for cancer sonodynamic and photodynamic therapy14 Oct 2010US 2010/0262115 A1
Most cited
By later US patents